# A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants

> **NCT04033458** · PHASE1 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 1 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-64140284

## Key facts

- **NCT ID:** NCT04033458
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-29
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** stopped because of a business decision
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04033458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04033458, "A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04033458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*